Literature DB >> 34492304

Colonization resistance against multi-drug-resistant bacteria: a narrative review.

R Le Guern1, S Stabler2, P Gosset3, M Pichavant3, T Grandjean3, E Faure2, Y Karaca3, K Faure2, E Kipnis4, R Dessein5.   

Abstract

Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.
Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbapenemase-producing Enterobacterales; Cross-infection; Extended-spectrum beta-lactamase; Gastrointestinal microbiome; Klebsiella pneumoniae; Microbiota; Vancomycin-resistant enterococci

Mesh:

Substances:

Year:  2021        PMID: 34492304     DOI: 10.1016/j.jhin.2021.09.001

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

Review 1.  [Role of the gut microbiome in the development and transfer of antibiotic resistances].

Authors:  Tobias M Appel; Maria J Vehreschild
Journal:  Inn Med (Heidelb)       Date:  2022-09-01

Review 2.  The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases.

Authors:  Rohma Ghani; Benjamin H Mullish; Lauren A Roberts; Frances J Davies; Julian R Marchesi
Journal:  Gut Microbes       Date:  2022 Jan-Dec

3.  Green synthesis of silver nanoparticles through oil: Promoting full-thickness cutaneous wound healing in methicillin-resistant Staphylococcus aureus infections.

Authors:  Yuhan Wang; Qinmei Li; Xiaomin Peng; Zheng Li; Jun Xiang; Yunru Chen; Kaiyuan Hao; Shuaiyang Wang; Dongyang Nie; Yao Cui; Feifei Lv; Ying Wang; Wenda Wu; Dawei Guo; Hongbin Si
Journal:  Front Bioeng Biotechnol       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.